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Instructions for Authors 
Please read the Instructions for Authors carefully. Your 
compliance with the given guidelines will facilitate the 
processing of your manuscript and will contribute to a 
prompt response. 
Clinical Microbiology azd Iiziction (CMI), a quaterly publication 
in English of the European Society of Clinical Microbiology 
and Infectious Diseases, will consider for publication manu- 
scripts concerned with infectious diseases in a broad sense: 
clinical and basic niicrobiology and parasitology; the diag- 
nosis, management and therapy of bacterial, viral, fungal and 
parasitic infections; the molecular pathogenesis of infectious 
diseases; immune mechanisms; nosoconiial infections and 
infections in the immunodepressed host; epidemiology, 
prophylaxis and vaccination; and other related subjects. 
Clinical Microbiolopy arid Injection will accept manuscripts for 
publication in the following categories: 
Original Articles of 3000-5000 words, with an abstract of 
Reviews; 
Notes and Comments; 
Brief Technical Reports of 1000-1500 words, with an 
Letters to the Editors; 
Continuing Education, with a self-evaluation component. 
Manuscript5 niust be accompanied by a letter signed by the 
corresponding author stating that the Instructions to Authors 
have been read, and that the author agrees to comply with 
these instructions and accept the condition5 posed. The letter 
should state that all named authors have seen and agreed to 
the submitted version of the manuscript, that all those 
acknowledged as contributors have agreed to their inclusion, 
that the material is original, and that it has neither been 
published elsewhere nor been simultaneously submitted for 
publication in another journal. 
The date of acceptance of Original Articles will be published 
with the article. Upon acceptance for publication, manu- 
scripts will become the permanent property of CMI and may 
not be published elsewhere without the permi5sion of the 
publisher. 
Copyright 
150-200 words; 
abstract of about 50 words; 
Material which has appeared in print elsewhere must be 
submitted with a release from the copyright holder. 
Reviewers 
The author is invited to submit the names of two potential 
reviewers, one of whom will be selected to review the 
manuscript in conjunction with a second reviewer chosen by 
the Editors. The addresses and fax numbers of the reviewers 
proposed should be included. If potential reviewers are not 
proposed at the time the manuscript is submitted, the Editors 
will refer the manuscript for review without further inquiry. 
Manuscript Preparation 
Manuscripts must be submitted in triplicate (original plus 
two copies). The entire manuscript, including the abstract, 
acknowledgements, references, tables, figures and legends, 
must be typewritten, double-spaced, on standard-size heavy 
duty bond paper, with a margin of at least 2.5 cm. A diskette 
should be included, labelled with the name ofthe manuscript, 
the file name of the final version and the word processing 
system used. If possible, the file should be in Wordperfect or 
Word. Otherwise, it should be supplied in ASCII format. 
On receipt, each manuscript will be assigned a number which 
will be provided to the author for use in all ensuing 
correspondence concerning the article. 
Title Page 
The title page must include each author’s full name, highest 
degree or diploma, and academic affiliations. The author 
to whom correspondence and reprint requests should be 
addressed must appear on  the first page of the manuscript 
(“Corresponding author and reprint requests: Title, name”) 
together with the full corresponding address, telephone and 
fax numbers of this author. 
Running Heading 
A running heading of forty-five letters or spaces maximum 
should be supplied, giving the most important element(s) of 
the paper. 
Abstract 
A structured abstract must be provided as part of each 
Original Article (150 to 200 words) and each Brief Tech- 
nical Report (50 words). The abstract should consist of 
four paragraphs with the following headings: Objectives, 
Methods, Results, Conclusions. The abstract page should 
bear the title of the manuscript. The abstract should not refer 
to footnotes or references. Three to ten key words must be 
included at the end of the abstract. 
References 
The author is responsible for the accuracy and completeness 
of the references. 
The references must be numbered sequentially, according to 
the order offirst citation in the manuscript, not alphabetically. 
Keferences should be cited in the text as numbers in paren- 
theses before punctuation marks. References to personal 
communications and unpublished material must be incor- 
porated, in parentheses, at the appropriate place in the text. 
References to meeting abstracts should be listed in the 
Reference section if they have been officially published as part 
of the meeting’s proceedings. They should, otherwise, only 
be referred to in parentheses in the text. 
References to articles submitted for publication should be 
included as “unpublished observations”. “In press” should be 
used only for articles accepted for publication. 
References must be listed in the Reference section according 
to the Vancouver style (see examples below). 
References to journal articles must include: 
1. 
2. 
3. 
4. 
5. 
6. 
authors’ names followed by initials. All authors up 
to six can be listed or three authors followed by 
‘let al.” 
title of the article 
title of the journal as abbreviated in the Index Medicus 
year of publication 
volume number 
first and last page numbers. 
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References to books must include: 
1 .  authors’ names followed by initials 
2. title of chapter 
3. editor(s) 
4. title of book in italics 
5. place of publication, publisher and year of publication 
6. first and last page numbers. 
Examples of References 
Article 
1. Bulkow LR, Wainwright RB, Letson GW, Chang SJ, 
Ward JI. Comparative immunogenicity of four Haemo- 
philus infuenzae type b conjugate vaccines in Alaska Native 
infants. Pediatr Infect Dis 1993; 12: 484-92. 
Article from a Supplement 
1. Jennings H. Further approaches for optimizing poly- 
saccharide-protein conjugate vaccines for the prevention 
of bacterial disease. J Infect Dis 1992; 165 (Suppl 1): 
S156-9. 
Book 
1. Altman DG. Practical statisrics for medical research. London: 
Chapter of a Book 
1. Apicella M. Neisseria meningitidis. In: Mandell GI Douglas 
R, Bennet J, eds. Principles and practice of infectious diseases. 
New York: Medical Publications, 1989: 1600-13. 
Chapman and Hall, 1991. 
Published Letter 
1. Rivas M, Toma C, Miliwebsky E, et al. Cholera isolates 
in relation to the “eighth pandemic” (letter). Lancet 1993; 
342: 926-7. 
Meeting Abstract 
1. Eskola J, Takala AK, Kayhty H, Koskenniemi E, Peltola 
H, Makela PH. Protection achieved by Haemophilus 
inzuenzae type b (Hib) conjugate vaccines is better than 
expected on the basis of efficacy trials (Abstract 979). In: 
Program and abstracts of the 32nd International Con- 
ference on Antimicrobial Agents and Chemotherapy 
(Anaheim, CA). Washington, DC: American Society for 
Microbiology, 1992; 273. 
Tables and Figures 
The data reported in a table or figure should be illustrative of 
information reported in the text and care should be taken not 
to be redundant. Tables and figures must be submitted in 
triplicate (one original and two copies). 
Each table must be presented on a separate page and 
numbered in order of appearance in the text. The title of 
the table must appear after its number. Footnotes, where 
necessary, must be identified by numbers. Units of measure- 
ment must be clearly indicated. 
Each figure must be submitted as a glossy 13 x 18 cm print. 
On the reverse side of each figure, the number of the figure, 
the title of the manuscript, the name of the corresponding 
author, and the proper orientation of the figure must be 
clearly indicated. Each set of figures should be submitted in 
a separate envelope labelled with the title of the manuscript. 
The figure legends are to be written on a separate page 
following the body of the manuscript. Legends should explain 
the figures in detail. 
Acknowledgements 
If a manuscript was previously presented in part at a meeting, 
this must be acknowledged, giving the title, location and date 
of the meeting. 
People should be acknowledged by their full name. 
Sources of funding should be acknowledged. 
Abbreviations 
Abbreviations in the text are discouraged. If a term appears 
repeatedly, however, an abbreviation may be introduced 
parenthetically at the initial mention of the term, and used in 
its place thereafter. Abbreviations for SI units may be used 
without introduction. 
References to Bacteria 
The genus and species of bacteria should be written in italics. 
The genus can be abbreviated to a single letter after having 
been mentioned in full at the beginning as long as this 
does not introduce any ambiguity (eg. I? for Proteus and 
Pseudomonas in the same text). 
References to Drugs 
The generic name of a drug should be used. However, the 
commercial name of the drug may be given in the Materials 
and Methods section and once in parenthesis afier the generic 
name at the beginning of the manuscript if this helps 
comprehension. 
Ethical Considerations 
Reports on biomedical research involving human subjects 
must include a statement that informed consent was obtained 
from each subject or their guardian. Reports on human 
experimentation must include a statement of approval by a 
local Human Investigations Committee, in accordance with 
the Helsinki Declaration. 
Manuscripts should be submitted to: 
Judith Crane, 
Editorial Ofice, 
Clinical Microbiology and Infection, 
Universiti. Paris VI, 
15, rue de 1’Ecole de Mtdecine, 
75270 Paris Cedex 06, France 
Tel: (33) 1 43 25 12 82 Fax: (33) 1 43 25 12 54 
